R.E. Bouwstra, BSc

No picture available
r.e.bouwstra umcg.nl


  1. Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?

    Bouwstra, R., van Meerten, T. & Bremer, E., 1-Jan-2019, In : Molecular and Cellular Oncology. 6, 3, 3 p., 1600349.

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  2. CD47 Expression Defines the Efficacy of Rituximab in Non-Germinal Center B-Cell (non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

    Van Meerten, T., Bouwstra, R., He, Y., Janneke, D. B., Kooistra, H., Fehrmann, R., Ammatuna, E., Huls, G. & Bremer, E., 29-Nov-2018, In : Blood. 132, Suppl.1, 3 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

    He, Y., Bouwstra, R., Wiersma, V. R., de Jong, M., Lourens, H. J., Fehrmann, R., de Bruyn, M., Ammatuna, E., Huls, G., van Meerten, T. & Bremer, E., 1-Feb-2019, In : Nature Communications. 10, 1, 8 p., 533.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (4) »

ID: 42067903